QLT up on Visudyne sales preview

QLT (QLTI; TSE:QLT) was up $5.19 (23%) to $27.39 on Thursday after reporting that the first quarter sales of Visudyne photodynamic therapy for age-related macular degeneration (AMD) were $48 million, ...